INDU.A

333.4

+1.28%↑

INDU.C

333.8

+1.21%↑

AZA

307.5

-3.61%↓

ORES

119.6

+1.37%↑

INDU.A

333.4

+1.28%↑

INDU.C

333.8

+1.21%↑

AZA

307.5

-3.61%↓

ORES

119.6

+1.37%↑

INDU.A

333.4

+1.28%↑

INDU.C

333.8

+1.21%↑

AZA

307.5

-3.61%↓

ORES

119.6

+1.37%↑

INDU.A

333.4

+1.28%↑

INDU.C

333.8

+1.21%↑

AZA

307.5

-3.61%↓

ORES

119.6

+1.37%↑

INDU.A

333.4

+1.28%↑

INDU.C

333.8

+1.21%↑

AZA

307.5

-3.61%↓

ORES

119.6

+1.37%↑

Biotage AB

Отворен

140.6 -0.64

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

140.1

Максимум

141.5

Ключови измерители

By Trading Economics

Приходи

97M

158M

Продажби

92M

582M

P/E

Средно за сектора

25.507

20.525

EPS

1.416

Дивидентна доходност

1.82

Марж на печалбата

27.148

Служители

680

EBITDA

111M

222M

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

1.82%

4.36%

Следващи печалби

16.07.2025 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-3.9B

7.2B

Предишно отваряне

141.24

Предишно затваряне

140.6

Biotage AB Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

22.04.2025 г., 06:50 ч. UTC

Придобивния, сливания и поглъщания

KKR Launches $1.2 Billion Takeover Bid For Swedish Life-Sciences Company Biotage

22.04.2025 г., 06:04 ч. UTC

Придобивния, сливания и поглъщания

KKR: Offer Price Represents 60% Premium to Thursday's Closing Price

22.04.2025 г., 06:03 ч. UTC

Придобивния, сливания и поглъщания

KKR: Biotage Board Recommends Shareholders Accept Offer

22.04.2025 г., 06:02 ч. UTC

Придобивния, сливания и поглъщания

KKR: Offer Values Biotage at SEK11.61B

22.04.2025 г., 06:02 ч. UTC

Придобивния, сливания и поглъщания

KKR Makes SEK145 a Share Bid For Biotage

Сравнение с други в отрасъла

Ценова промяна

Biotage AB Прогноза

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Biotage AB

Biotage AB (publ) provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, and work-up products; flash systems; sample preparation products; plasmid purification solutions; oligo synthesis solutions; and metal scavengers and reagents, as well as accessories and spare parts. It also provides sample preparation solutions in the clinical and bioanalytical, forensic and toxicology, doping control animal and human, environment, and food and agriculture areas, as well as consumables and systems; protein purification solutions, including antibody and tagged proteins purification, automation systems, and custom packing service, as well as ion exchange, reversed phase, normal phase, and gel filtration PhyTip columns. The company sells its products to pharmaceutical and biotechnical companies, contract research and manufacturing organizations, diagnostics, clinical, environmental protection, food safety, clinical, forensic, and academic laboratories industries. It operates in more than 80 countries, which include Americas, Europe, the Middle East, Africa, and Asia Pacific. Biotage AB (publ) was founded in 1969 and is headquartered in Uppsala, Sweden.